Bioteque Corporation (TPEX:4107)
Taiwan · Delayed Price · Currency is TWD 114.50
+1.00 (0.88%)
May 29, 2026, 1:30 PM CST
Bioteque Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,163 | 2,135 | 2,073 | 1,945 | 2,010 | 1,825 | |
Revenue Growth (YoY) | 3.27% | 3.03% | 6.58% | -3.26% | 10.12% | -6.27% |
Cost of Revenue | 1,204 | 1,199 | 1,167 | 1,126 | 1,166 | 1,023 |
Gross Profit | 959.27 | 936.94 | 905.08 | 818.94 | 844.54 | 802.87 |
Selling, General & Admin | 195.91 | 193.36 | 185.65 | 168.32 | 196.19 | 186.11 |
Research & Development | 76.19 | 73.3 | 76.26 | 70.44 | 69.98 | 68.83 |
Operating Expenses | 272.1 | 266.66 | 261.91 | 238.76 | 266.17 | 254.94 |
Operating Income | 687.17 | 670.28 | 643.17 | 580.18 | 578.38 | 547.93 |
Interest Expense | -7.27 | -7.54 | -9.37 | -11.6 | -4.32 | -1.9 |
Interest & Investment Income | 14.74 | 15.35 | 13.53 | 10.97 | 2.14 | 0.73 |
Currency Exchange Gain (Loss) | -6.51 | -6.51 | 20.47 | -11.55 | 33.77 | -10.84 |
Other Non Operating Income (Expenses) | 1.54 | 4.83 | 11.07 | -1.64 | 3.57 | 5.18 |
EBT Excluding Unusual Items | 689.67 | 676.41 | 678.87 | 566.35 | 613.53 | 541.11 |
Gain (Loss) on Sale of Investments | -1.79 | -1.79 | 5.44 | 3.16 | 9.65 | -2.91 |
Gain (Loss) on Sale of Assets | - | - | -5.94 | - | - | - |
Pretax Income | 687.89 | 674.62 | 678.37 | 569.52 | 623.18 | 538.2 |
Income Tax Expense | 138.26 | 135.44 | 150.11 | 116.97 | 129.64 | 106.94 |
Net Income | 549.63 | 539.19 | 528.26 | 452.55 | 493.54 | 431.26 |
Net Income to Common | 549.63 | 539.19 | 528.26 | 452.55 | 493.54 | 431.26 |
Net Income Growth | 2.33% | 2.07% | 16.73% | -8.30% | 14.44% | -11.75% |
Shares Outstanding (Basic) | 54 | 69 | 69 | 69 | 69 | 69 |
Shares Outstanding (Diluted) | 54 | 70 | 70 | 70 | 70 | 70 |
Shares Change (YoY) | -22.19% | 0.09% | 0.01% | -0.03% | 0.07% | 0.01% |
EPS (Basic) | 10.22 | 7.78 | 7.62 | 6.53 | 7.12 | 6.22 |
EPS (Diluted) | 10.15 | 7.74 | 7.59 | 6.50 | 7.09 | 6.20 |
EPS Growth | 31.63% | 1.98% | 16.77% | -8.32% | 14.36% | -11.68% |
Free Cash Flow | 607.49 | 607 | 604.49 | 606.62 | -82.25 | -81.63 |
Free Cash Flow Per Share | 11.21 | 8.71 | 8.68 | 8.71 | -1.18 | -1.17 |
Dividend Per Share | 5.500 | 5.500 | 5.000 | 4.500 | 4.500 | 4.500 |
Dividend Growth | 10.00% | 10.00% | 11.11% | - | - | 12.50% |
Gross Margin | 44.34% | 43.88% | 43.67% | 42.11% | 42.01% | 43.98% |
Operating Margin | 31.77% | 31.39% | 31.03% | 29.83% | 28.77% | 30.01% |
Profit Margin | 25.41% | 25.25% | 25.49% | 23.27% | 24.55% | 23.62% |
Free Cash Flow Margin | 28.08% | 28.43% | 29.17% | 31.19% | -4.09% | -4.47% |
EBITDA | 844.09 | 825.63 | 791.52 | 721.32 | 698.87 | 662.61 |
EBITDA Margin | 39.02% | 38.66% | 38.19% | 37.09% | 34.77% | 36.30% |
D&A For EBITDA | 156.92 | 155.35 | 148.35 | 141.14 | 120.49 | 114.68 |
EBIT | 687.17 | 670.28 | 643.17 | 580.18 | 578.38 | 547.93 |
EBIT Margin | 31.77% | 31.39% | 31.03% | 29.83% | 28.77% | 30.01% |
Effective Tax Rate | 20.10% | 20.08% | 22.13% | 20.54% | 20.80% | 19.87% |